Development of non-viral, ligand-dependent, EPHB4-specific chimeric antigen receptor T cells for treatment of rhabdomyosarcoma
Ephrin type-B receptor 4 (EPHB4), expressed in tumors including rhabdomyosarcoma, is a suitable target for chimeric antigen receptor (CAR)-T cells. Ligand-independent activation of EPHB4 causes cell proliferation and malignant transformation in rhabdomyosarcoma, whereas ligand-dependent stimulation...
Guardat en:
| Autors principals: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2021-03-01
|
| Col·lecció: | Molecular Therapy: Oncolytics |
| Matèries: | |
| Accés en línia: | http://www.sciencedirect.com/science/article/pii/S2372770521000334 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
